Slide 1 Molecular pathology of endometrial carcinoma Dr James Duhig Slide 2 Slide 3 Can form ever fully inform us of function? Slide 4 Slide 5 Molecular pathology Tumours…

Slide 1K-Ras and Beyond Josep Tabernero, MD Vall d’Hebron University Hospital Barcelona, Spain Slide 2 Disclosures Participated in Advisory Boards of Merck, Amgen, Imclone,…

Slide 1 What is on the horizon for new therapeutics for gynecologic cancers? Ursula Matulonis, M.D. May 9, 2015 Slide 2 Agenda Discuss our program’s goals at DFCI for 2015…

Slide 1 Colorectal Cancer: What Next? Neal J. Meropol, MD Chief, Hematology and Oncology University Hospitals Case Medical Center Case Western Reserve University January…

Slide 1 Introduction Phosphatidylinositol 3 ′ -kinase (PIK3CA) encodes for a lipid kinase that regulates signaling pathways downstream of EGFR and is mutated in 10% to…

Nuovi inibitori irreversibili di EGFR Cesare Gridelli Division of Medical Oncology âS.G. Moscatiâ Hospital â Avellino (Italy) [email protected] 1 N= 440 patients Stratification…

Not division⦠But growth Cells must grow PI3K GFR Akt Rheb Ras mTOR Tuberin/ Hamartin PTEN Neurofibromin Tuberous sclerosis complex Neurofibromatosis type 1 (NF1) Cowden…

Dr. Qun Lu Leo Jenkins Cancer Center at BSOM UNC Lineberger Comprehensive Cancer Center Contextual Contributions of Oncogenic and Tumor Suppressive Pathways: - Our Opportunities…

LWWUS_PAS_201288 433..443The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory Robert J. Kurman, MD and Ie-Ming Shih, MD, PhD Abstract: Ovarian